MASS Stock Analysis: Buy, Sell, or Hold?
MASS - 908 Devices Inc. Common Stock
$6.61
0.40 (6.44%)
▲
5d:
+7.65%
30d:
-1.93%
90d:
+25.9%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When MASS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MASS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: MASS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: MASS is currently trading at $6.61, which is considered slightly high relative to its 30-day fair value range of $6.01 to $6.64.
Technical Outlook: Technically, MASS is in a uptrend. The price is approaching resistance at $6.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.4% recently.
Market Sentiment: MASS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+51.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MASS is in a uptrend. The price is approaching resistance at $6.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.4% recently.
Market Sentiment: MASS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+51.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$6.01 -
$6.64
Company Quality Score
52/100
(HOLD)
Options IV Signal
40th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
81.2%
All Signals
- NEUTRAL: Options fairly priced (IV 40th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.4%)
- BULLISH: Trading 51.3% below Wall St target ($10.00)
Fair Price Analysis
30-Day Fair Range
$6.01 -
$6.64
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
±$0.84
(12.7%)
Support & Resistance Levels
Support Level
$5.70
Resistance Level
$6.53
Current Trend
Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-22.41
Wall Street Target
$10.00
(+51.3%)
Revenue Growth (YoY)
-7.7%
Profit Margin
34.7%
Share & Embed Analysis
Last updated: April 02, 2026 5:47 PM ET
Data refreshes hourly during market hours. Next update: 6:47 PM
Data refreshes hourly during market hours. Next update: 6:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MASS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Joseph H Iv Griffith
SELL
23175 shares
2026-02-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 52 HOLD |
